Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extended Spectrum Beta-Lactamase Producing Bacteria Infection”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableLooking for participantsNCT06258551
What this trial is testing

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Who this might be right for
Antimicrobial Drug ResistanceAntibiotic Resistant InfectionClostridium Difficile+5 more
The Methodist Hospital Research Institute 1,000
Not applicableStudy completedNCT01838213
What this trial is testing

Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients

Who this might be right for
Urinary Tract InfectionInfection Due to ESBL BacteriaEnvironmental Contamination of ESBL
Vestre Viken Hospital Trust 760
Not applicableStudy completedNCT01531023
What this trial is testing

Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice

Who this might be right for
Urinary Tract Infections
University of Oslo 168
Large-scale testing (Phase 3)Study completedNCT04172012
What this trial is testing

Use of Probiotics to Reduce Infections, Death and ESBL Colonisation

Who this might be right for
Neonatal Sepsis
Haydom Lutheran Hospital 2,000
Not applicableStudy completedNCT00167999
What this trial is testing

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Who this might be right for
Gram-Positive Bacterial InfectionsEscherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 200
Large-scale testing (Phase 3)WithdrawnNCT04238390
What this trial is testing

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection

Who this might be right for
Bacteremia Caused by Gram-Negative Bacteria
The University of Queensland
Not applicableStudy completedNCT02142933
What this trial is testing

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Who this might be right for
Group B Streptococcal InfectionInfection Due to ESBL Bacteria
University Hospital, Basel, Switzerland 250
Not applicableUnknownNCT04131569
What this trial is testing

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection

Who this might be right for
Extended Spectrum Beta-Lactamase Producing Bacteria InfectionMicrobial ColonizationCritical Illness
University of Bordeaux 60
Not applicableStudy completedNCT01296165
What this trial is testing

International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli

Who this might be right for
Infection Due to Resistant Bacteria
Johann DD Pitout 173